Perrigo Company (PRGO) announced it has received final approval from the U.S. FDA for its abbreviated new drug applications for fluocinolone acetonide scalp oil, 0.01%, the generic equivalent to Derma-Smoothe/FS Scalp Oil, and fluocinolone acetonide topical oil, 0.01%, the generic equivalent to Derma-Smoothe/FS Body Oil.
Derma-Smoothe/FS Scalp Oil and Derma-Smoothe/FS Body Oil are indicated for the topical treatment of atopic dermatitis in adult patients and the topical treatment of moderate to severe atopic dermatitis in pediatric patients 3 months and older for up to 4 weeks. Perrigo expects to begin shipments of both products next month.
Click here to receive FREE breaking news email alerts for Perrigo Co. and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org